Skip to content

A study on the effects of radiotherapy on hearing in patients with unilateral parotid gland tumors

A study on the effects of radiotherapy on hearing in patients with unilateral parotid gland tumors - RTototox

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON32836
Enrollment
80
Registered
2009-10-29
Start date
2009-11-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ototoxicity hearing loss

Interventions

None listed

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Patiënts with benig or malignant parotid tumor 2. Unilateral treatment by surgery and postoperative radiotherapy 3. Treated after 01-01-2000 4. Treatment with curative intent 5. No other ototoxic treatment 6. No signs of recurrence and/or distant metastases

Exclusion criteria

Exclusion criteria: Preexistent asymetric hearing loss

Design outcomes

Primary

MeasureTime frame
Hearing loss Prognostic parameters of hearing loss Social impact of hearing loss

Secondary

MeasureTime frame
Prognostic parameters of hearing loss Social impact of hearing loss

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)